1cir

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1cir.jpg|left|200px]]
[[Image:1cir.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1cir |SIZE=350|CAPTION= <scene name='initialview01'>1cir</scene>
+
The line below this paragraph, containing "STRUCTURE_1cir", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=HSE:L-HOMOSERINE'>HSE</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1cir| PDB=1cir | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1cir FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1cir OCA], [http://www.ebi.ac.uk/pdbsum/1cir PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1cir RCSB]</span>
+
-
}}
+
'''COMPLEX OF TWO FRAGMENTS OF CI2 [(1-40)(DOT)(41-64)]'''
'''COMPLEX OF TWO FRAGMENTS OF CI2 [(1-40)(DOT)(41-64)]'''
Line 27: Line 24:
[[Category: Davis, B J.]]
[[Category: Davis, B J.]]
[[Category: Fersht, A R.]]
[[Category: Fersht, A R.]]
-
[[Category: serine protease inhibitor]]
+
[[Category: Serine protease inhibitor]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 12:46:39 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 19:22:32 2008''
+

Revision as of 09:46, 2 May 2008

Template:STRUCTURE 1cir

COMPLEX OF TWO FRAGMENTS OF CI2 [(1-40)(DOT)(41-64)]


Overview

BACKGROUND: Single-module proteins, such as chymotrypsin inhibitor 2 (CI2), fold as a single cooperative unit. To solve its folding pathway, we must characterize, under conditions that favour folding, its denatured state, its transition state, and its final folded structure. To obtain a "denatured state' that can readily be thus characterized, we have used a trick of cleaving CI2 into two complementary fragments that associate and fold in a similar way to intact protein. RESULTS: Fragment CI2(1-40)-which contains the sequence of the single alpha-helix, spanning residues 12-24-and CI2(41-64), and mutants thereof, were analyzed by NMR spectroscopy, the transition state for association/folding was characterized by the protein engineering method, and the structure of the complex was solved by NMR and X-ray crystallography. Both isolated fragments are largely disordered. The transition state for association/folding is structured around a nucleus of a nearly fully formed alpha-helix, as is the transition state for the folding of intact CI2, from residues Ser12 to Leu21, Ala16, a residue from the helix whose sidechain is buried in the hydrophobic core, makes interactions with Leu49 and Ile57 in the other fragment. Ala16 makes its full interaction energy in the transition state for the association/folding reaction, just as found during the folding of the intact protein. CONCLUSIONS: The specific contacts in the transition state from a nucleus that extends from one fragment to the next, but the nucleus is only "flickeringly' present in the denatured state. This is direct evidence for the nucleation-condensation mechanism in which the nucleus is only weakly formed in the ground state and develops in the transition state. The low conformational preferences in the denatured state are not enough to induce significant local secondary structure, but are reinforced by tertiary interactions during the rapid condensation around the nucleus.

About this Structure

1CIR is a Protein complex structure of sequences from Hordeum vulgare. Full crystallographic information is available from OCA.

Reference

Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism., Neira JL, Davis B, Ladurner AG, Buckle AM, Gay Gde P, Fersht AR, Fold Des. 1996;1(3):189-208. PMID:9079381 Page seeded by OCA on Fri May 2 12:46:39 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools